NCT06402734

Brief Summary

This study examined the impact of a gluten-free diet on nutritional status and inflammation markers in adult celiac patients compared to a control group. Twenty-six celiac patients and 26 healthy individuals participated. Interviews, dietary records, anthropometric measurements, and blood samples were collected. After six weeks, celiac patients showed improved adherence to the gluten-free diet and increased quality of life scores. While initial micronutrient intake was lower in celiac patients, it improved over the study period. However, there were no significant changes in inflammation markers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2020

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

May 3, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

1.3 years

First QC Date

May 3, 2024

Last Update Submit

May 3, 2024

Conditions

Keywords

celiac diseaseinflammationinterferon-gammainterleukin-15

Outcome Measures

Primary Outcomes (4)

  • Serum interferon-gamma level

    Serum interferon-gamma level was measured.

    6 weeks

  • Serum interleukin-15 levels

    Serum interleukin-15 level was measured.

    6 weeks

  • Body weight

    Body weight was measured using body composition analyzer device.

    6 weeks

  • Lean body mass

    Lean body mass was measured using body composition analyzer device.

    6 weeks

Secondary Outcomes (1)

  • Total energy intake

    6 weeks

Study Arms (2)

Celiac Disease

Adult patients who were diagnosed with celiac disease were enrolled in the study.

Behavioral: Adherence to Gluten Free Diet

Healthy Subjects

Healthy subjects with matching demographical characteristics to the celiac group were enrolled in the study.

Interventions

Participants with a diagnosed celiac disease were following a gluten-free diet. Study observed the adherence to the gluten-free diet for 6 weeks.

Celiac Disease

Eligibility Criteria

Age19 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The study population consisted of 26 individuals diagnosed with celiac disease, comprising 21 females and 5 males, aged between 18 and 64 years. Additionally, a healthy control group of 26 individuals, including 20 females and 6 males, without any known diseases, was included in the study.

You may qualify if:

  • Adults aged between 19 and 64 years old.
  • Diagnosis of celiac disease.
  • Willingness to participate in the study.
  • Ability to adhere to the study protocol, including dietary restrictions and follow-up assessments.
  • For the control group, individuals without celiac disease or any other significant health conditions.

You may not qualify if:

  • Individuals following diets other than a gluten-free diet.
  • Individuals adhering to a gluten-free diet for reasons other than celiac disease.
  • Individuals with gastrointestinal diseases other than celiac disease.
  • Individuals who have undergone gastrointestinal surgery.
  • Individuals with mental illnesses.
  • Cancer patients.
  • Individuals positive for hepatitis B surface antigen or anti-hepatitis C virus antibody.
  • Individuals using interferon and/or insulin.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University Nutrition and Dietetics Department

Ankara, 06100, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples were collected from all subjects.

MeSH Terms

Conditions

Celiac DiseaseInflammation

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Zeynep Goktas, PhD

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 3, 2024

First Posted

May 7, 2024

Study Start

October 15, 2018

Primary Completion

January 15, 2020

Study Completion

March 15, 2020

Last Updated

May 7, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Due to the ethical reasons participant data will not be shared.

Locations